PI Pharma Insight

BNF presentation directory

Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.

Reset

Active filters

  • Chemical substance: Sennosides
Presentation Product Chemical substance Chapter Items dispensed
Sennosides 7.5mg/5ml oral solution sugar free
0106020V0AAABAB
Sennosides Sennosides Gastro-Intestinal System 26,508
Senokot 7.5mg/5ml Syrup 12 Years Plus (Reckitt)
0106020V0BCABAB
Senokot (Sennosides) Sennosides Gastro-Intestinal System 3,343
Sennosides 7.5mg tablets
0106020V0AAAAAA
Sennosides Sennosides Gastro-Intestinal System 2,178
Cenlax 7.5mg tablets 12 Years Plus
0106020V0BBAAAA
Cenlax Sennosides Gastro-Intestinal System 37
Senease Twelve Years Plus 7.5mg tablets
0106020V0BDABAA
Senease Sennosides Gastro-Intestinal System 37
Senokot 7.5mg/5ml Syrup 12 Years Plus (Forum)
0106020V0BCAAAB
Senokot (Sennosides) Sennosides Gastro-Intestinal System 2
Senease Eighteen Years Plus 7.5mg tablets
0106020V0BDAAAA
Senease Sennosides Gastro-Intestinal System No data available
Senease Twelve Years Plus 7.5mg/5ml syrup
0106020V0BDACAB
Senease Sennosides Gastro-Intestinal System No data available

Why monitor BNF codes?

Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.

Track cost pressure

Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.

Understand demand drivers

Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.